Abiopharma

🔍 Mark Martin Elias (Executive)

Company: Gambling.com Group Ltd (GAMB)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 9,990 shares of Ordinary Shares at $3.72 per share (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 787,888.00 | transaction_form_type: 4
• Sold 9,990 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 64,493.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Acquired 160,272 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 224,765.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2, F2

Footnotes:

• F1: Restricted stock units converted into common stock on a one-for-one basis.
• F2: Twenty-five percent of the RSUs vest on each of the first four anniversaries of the grant date, which is April 1, 2026.